Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study

被引：0

作者：

Fumery, M. ^{[1
]}

Defrance, A. ^{[2
]}

Roblin, X. ^{[3
]}

Altwegg, R. ^{[4
]}

Caron, B. ^{[5
]}

Hebuterne, X. ^{[6
]}

Carmen, S. ^{[7
]}

Meyer, A. ^{[8
]}

Nachury, M. ^{[9
]}

Laharie, D. ^{[10
]}

Nancey, S. ^{[11
]}

Le Berre, C. ^{[12
]}

Serrero, M. ^{[13
]}

Geyl, S. ^{[14
]}

Gilletta, C. ^{[15
]}

Soune, P. Ah ^{[16
]}

Duveau, N. ^{[17
]}

Uzza, M. ^{[18
]}

Abitbol, V. ^{[19
]}

Biron, A. ^{[20
]}

Minh, M. L. Tran ^{[21
]}

Paupard, T. ^{[22
]}

Vuitton, L. ^{[23
]}

Elgharabawy, Y. ^{[2
]}

Peyrin-Biroulet, L. ^{[5
]}

机构：

[1] Amiens Univ Hosp, Gastroenterol, Amiens 1, France

[2] GETAID, Paris, France

[3] St Etienne Univ Hosp, Gastroenterol, St Etienne, France

[4] Montpellier Univ Hosp, Gastroenterol, Montpellier, France

[5] Nancy Univ Hosp, Gastroenterol, Nancy, France

[6] Nice Univ Hosp, Gastroenterol, Nice, France

[7] GH Ambroise Pare Hartmann, Gastroenterol, Neuilly, France

[8] Kremlin Bicetre, Gastroenterol, Paris, France

[9] Lille Univ Hosp, Gastroenterol, Lille, France

[10] Bordeaux Univ Hosp, Gastroenterol, Bordeaux, France

[11] Lyon Univ Hosp, Gastroenterol, Lyon, France

[12] Nantes Univ Hosp, Gastroenterol, Nantes, France

[13] Marseille Univ Hosp, Gastroenterol, Marseille, France

[14] Limoges Univ Hosp, Gastroenterol, Limoges, France

[15] Toulouse Univ Hosp, Gastroenterol, Toulouse, France

[16] Toulon Hosp, Gastroenterol, Toulon, France

[17] Roubaix Hosp, Gastroenterol, Roubaix, France

[18] Hop Mondor, Gastroenterol, Creteil, France

[19] Hop Cochin, Paris, France

[20] Reims Univ Hosp, Gastroenterol, Reims, France

[21] St Louis Hosp, Gastroenterol, Paris, France

[22] Dunkerque Hosp, Gastroenterol, Dunkerque, France

[23] Besancon Univ Hosp, Gastroenterol, Besancon, France

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P638

引用

页码：770 / 770

页数：1

共 50 条

[31] Comparative real-world effectiveness of vedolizumab and ustekinumab for patients with ulcerative colitis: a GETAID multicentre cohort study
Meyer, Antoine
Fumery, Mathurin
Peyrin-Biroulet, Laurent
Filippi, Jerome
Altwegg, Romain
Bouhnik, Yoram
Serrero, Melanie
Laharie, David
Roblin, Xavier
Nachury, Maria
Abitbol, Vered
Cadiot, Guillaume
Nancey, Stephane
Allez, Matthieu
Gilletta, Cyrielle
Vuitton, Lucine
Savoye, Guillaume
Nahon, Stephane
Bourrier, Anne
Buisson, Anthony
Bouguen, Guillaume
Bourreille, Arnaud
Viennot, Stephanie
Carbonnel, Franck
Amiot, Aurelien
[J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 1454 - 1462
[32] Comparison of safety and mortality of infliximab therapy to immunomodulator therapy in Crohn's disease: A cohort study
Doumit, J
Brzezinski, A
Lashner, B
Achkar, JP
Lopez, R
Shen, B
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S306 - S306
[33] Long-Term Outcome of Enterocutaneous Fistula in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Cohort Study from the GETAID
Amiot, Aurelien
Setakhr, Vida
Seksik, Philippe
Allez, Mathieu
Treton, Xavier
De Vos, Martine
Laharie, David
Colombel, Jean-Frederic
Abitbol, Vered
Reimund, Jean Marie
Moreau, Jacques
Veyrac, Michel
Flourie, Bernard
Cosnes, Jacques
Lemann, Marc
Bouhnik, Yoram
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (09): : 1443 - 1449
[34] A retrospective observational study on the effectiveness and safety of vedolizumab with or without budesonide induction therapy among patients with moderate-to-severe Crohn's disease
Weisshof, R.
Vavricka, S.
Pouillon, L.
Braegger, F.
Roset, M.
Bent-Ennakhil, N.
Ferrante, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S317 - S318
[35] Efficacy and safety of risankizumab in children with Crohn's disease: A preliminary report
Spencer, E.
Stein, R.
Shalem, T.
Zifman, E.
Dubinsky, M.
Tzion, R. Lev
Turner, D.
Assa, A.
[J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1435 - I1436
[36] Effectiveness of dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous ustekinumab maintenance therapy: A multicentre international cohort study
Kopylov, U.
Hanzel, J.
Liefferinckx, C.
De Marco, D.
Imperatore, N.
Plevris, N.
Baston-Rey, I.
Harris, R.
Truyens, M.
Domislovic, V.
Vavricka, S.
Biemans, V.
Myers, S.
Shaji, S.
Ben-Horin, S.
Gonzalez Lama, Y.
Gilletta, C.
Shitrit, A. Bar-Gil
Zelinkova, Z.
Weishof, R.
Storan, D.
Zittan, E.
Franchimont, D.
Cremer, A.
Afif, W.
Castiglione, F.
Lees, C.
Barrero de Acosta, M.
Lobaton, T.
Doherty, G.
Krznaric, Z.
Pierik, M.
Hoentjen, F.
Drobne, D.
[J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S111 - S111
[37] Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study
Thomas, Pepijn W. A.
van Caem, Mark
West, Rachel L.
Russel, Maurice G. V. M.
Jansen, Jeroen M.
Romkens, Tessa E. H.
Hoentjen, Frank
[J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (03) : 261 - 269
[38] EFFECTIVENESS OF CROHN'S DISEASE EXCLUSION DIET FOR INDUCTION OF REMISSION IN CROHN'S DISEASE ADULT PATIENTS
Szczubelek, Martyna
Pomorska, Karolina
Korolczyk-Kowalczyk, Monika
Lewandowski, Konrad
Kaniewska, Magdalena
Rydzewska, Grazyna
[J]. INFLAMMATORY BOWEL DISEASES, 2022, 28 : S24 - S25
[39] Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients
Szczubelek, Martyna
Pomorska, Karolina
Korolczyk-Kowalczyk, Monika
Lewandowski, Konrad
Kaniewska, Magdalena
Rydzewska, Grazyna
[J]. NUTRIENTS, 2021, 13 (11)
[40] EFFECTIVENESS OF CROHN'S DISEASE EXCLUSION DIET FOR INDUCTION OF REMISSION IN CROHN'S DISEASE ADULT PATIENTS
Szczubelek, Martyna
Pomorska, Karolina
Korolczyk-Kowalczyk, Monika
Lewandowski, Konrad
Kaniewska, Magdalena
Rydzewska, Grazyna
[J]. GASTROENTEROLOGY, 2022, 162 (03) : S24 - S25

← 1 2 3 4 5 →